Safety of 13-valent pneumococcal conjugate vaccine in infants and children: meta-analysis of 13 clinical trials in 9 countries
A Thompson, A Gurtman, S Patterson, C Juergens… - Vaccine, 2013 - Elsevier
Background: Meta-analyses enable summarization and interpretation of data across clinical
trials. When applied to safety data they allow for detection of rare events. Recently, a 13-
valent pneumococcal conjugate vaccine (PCV13) was approved in multiple countries
worldwide for routine immunization of infants and young children. This meta-analysis was
conducted to identify potentially clinically important rare safety events associated with
PCV13. Objective: To summarize the safety of PCV13 compared with 7-valent …
trials. When applied to safety data they allow for detection of rare events. Recently, a 13-
valent pneumococcal conjugate vaccine (PCV13) was approved in multiple countries
worldwide for routine immunization of infants and young children. This meta-analysis was
conducted to identify potentially clinically important rare safety events associated with
PCV13. Objective: To summarize the safety of PCV13 compared with 7-valent …
以上显示的是最相近的搜索结果。 查看全部搜索结果